Mahana Therapeutics

Closed

FDA-cleared digital CBT for IBS and chronic gastrointestinal conditions

San Francisco, United States · Founded 2018 · $61.0M raised

Employees
11–50
Founded
2018
Business Model
B2B2C
Website
mahana.com
Total Funding
$61.0M
Last Round
$61.0M Series BAug 2021
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Mahana Therapeutics was a San Francisco and London-based prescription digital therapeutics company co-founded in 2018 by Robert Paull and Simon Levy to deliver scalable, clinically validated cognitive behavioral therapy (CBT) for gastrointestinal disorders. Its flagship product, Mahana IBS (also called Parallel), was the first digital therapeutic to receive FDA clearance for the treatment of irritable bowel syndrome, delivering a structured 3-month CBT program via mobile app without requiring in-person visits. The company raised $61 million in a 2021 Series B led by JAZZ Venture Partners and Lux Capital, and subsequently signed a commercialization agreement with Bayer's Consumer Health division to expand market reach.

Summary

Mahana Therapeutics is a Biotech company based in San Francisco, United States, founded in 2018. It has raised $61.0M in total across 1 round, most recently a $61.0M Series B round in Aug 2021. Investors include Jazz Venture Partners, Gurnet Point Capital and Main Street Advisors.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2021
$61.0M

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mahana Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mahana-therapeutics"><img src="https://indexed.vc/api/badge/company/mahana-therapeutics" alt="Mahana Therapeutics on Indexed.vc" width="260" height="76" /></a>